Leukoplakia clinical trials at UCSD
1 in progress, 0 open to eligible people
Sorry, not currently recruiting here
This phase II pilot trial studies how well pembrolizumab works in treating leukoplakia. Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread.
La Jolla, California and other locations
Our lead scientists for Leukoplakia research studies include Ezra E. Cohen.